These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7749800)

  • 1. Underutilization of the Papanicolaou smear in human immunodeficiency virus-positive women.
    Strigle SM; Walts AE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):206. PubMed ID: 7749800
    [No Abstract]   [Full Text] [Related]  

  • 2. Papanicolaou smears in human immunodeficiency virus-seropositive women during follow-up.
    Heard I; Bergeron C; Jeannel D; Henrion R; Kazatchkine MD
    Obstet Gynecol; 1995 Nov; 86(5):749-53. PubMed ID: 7566842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interpretation of high-grade squamous intraepithelial lesion on anal cytology: a comparative analysis with the cervical Papanicolaou test.
    Patel AP; Schatz-Siemers NF; Dilcher TL; Goyal A
    J Am Soc Cytopathol; 2020; 9(6):540-549. PubMed ID: 32800528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative women.
    Branca M; Rossi E; Alderisio M; Migliore G; Morosini PL; Vecchione A; Sopracordevole F; Mudu P; Leoncini L; Syrjänen K
    Cytopathology; 2001 Apr; 12(2):84-93. PubMed ID: 11284952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of SIL and SCCA in human immunodeficiency virus-seropositive women at anonymous clinic in Chonburi Hospital.
    Hluangdansakul W; Phinchantra P; Bowonwatanuwong C
    J Med Assoc Thai; 2006 Mar; 89(3):289-93. PubMed ID: 16696410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cytology screening in HIV-positive women: completion of the audit cycle.
    Bates SM; Street EJ
    Int J STD AIDS; 2011 Oct; 22(10):615-6. PubMed ID: 21998191
    [No Abstract]   [Full Text] [Related]  

  • 7. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study.
    Wright TC; Ellerbrock TV; Chiasson MA; Van Devanter N; Sun XW
    Obstet Gynecol; 1994 Oct; 84(4):591-7. PubMed ID: 8090399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillomavirus in cervicovaginal smears of women infected with human immunodeficiency virus.
    Eduardo Calore E; José Cavaliere M; Kasumi Shirata N; Araújo MF
    Sao Paulo Med J; 1995; 113(6):1009-11. PubMed ID: 8731285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of Papanicolaou test among HIV-infected women.
    Anderson JR; Paramsothy P; Heilig C; Jamieson DJ; Shah K; Duerr A;
    Clin Infect Dis; 2006 Feb; 42(4):562-8. PubMed ID: 16421802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the cytologic reporting rate for high-grade squamous intraepithelial lesion or worse and Papanicolaou smear sensitivity: a simple mathematic proof with practical implications.
    Llewellyn H
    Cancer; 2007 Jun; 111(3):137-40; discussion 141-2. PubMed ID: 17516462
    [No Abstract]   [Full Text] [Related]  

  • 11. One Pap smear of benefit in developing countries.
    Bagchi S
    Lancet Oncol; 2005 Jan; 6(1):9. PubMed ID: 15672493
    [No Abstract]   [Full Text] [Related]  

  • 12. The Papanicolaou smear and the obstetric patient: a simple test with great benefits.
    Michael CW
    Diagn Cytopathol; 1999 Jul; 21(1):1-3. PubMed ID: 10405797
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Pap test in HIV-positive women].
    Carlucci M; Cimmino A; Fiore MG; Lepera A; Tantimonaco L; Ricco R
    Pathologica; 2001 Dec; 93(6):651-3. PubMed ID: 11785116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pap smear accuracy for the diagnosis of cervical precancerous lesions.
    Nkwabong E; Laure Bessi Badjan I; Sando Z
    Trop Doct; 2019 Jan; 49(1):34-39. PubMed ID: 30222058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
    Jain BB; Adhikary T; Sadhukhan PC; Nandi A
    J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening issues for HIV positive women: a physician's perspective.
    Bardaro L
    BETA; 1996 Jun; ():35-8. PubMed ID: 11363648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequacy of screening cervical cytology among human immunodeficiency virus-seropositive women.
    Spinillo A; Capuzzo E; Tenti P; De Santolo A; Piazzi G; Iasci A
    Gynecol Oncol; 1998 May; 69(2):109-13. PubMed ID: 9600816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical dysplasia and human immunodeficiency virus infection in women: prevalence and associated factors. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GESCA).
    Hocke C; Leroy V; Morlat P; Rivel J; Duluc MC; Boulogne N; Tandonnet B; Dupon M; Brun JL; Dabis F
    Eur J Obstet Gynecol Reprod Biol; 1998 Oct; 81(1):69-76. PubMed ID: 9846718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-yield of routine Papanicolaou smear screening in a clinic for sexually transmitted diseases.
    Tavelli BG; Judson FN; Hetrick AE; Root CJ
    Sex Transm Dis; 1985; 12(3):110-3. PubMed ID: 3929404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety against cervical precancer and cancer following negative human papillomavirus and Papanicolaou test results in human immunodeficiency virus-infected women.
    Castle PE; Fetterman B; Poitras N; Lorey T; Kinney W
    Arch Intern Med; 2012 Jul; 172(13):1041-3. PubMed ID: 22641193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.